Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids
Endocrine-Related Cancer, 08/28/09
Nilsson O et al. – The majority of tumours showed loss of chromosome 18, which most likely represents a primary event in the development and pathogenesis of tumours. A different genetic pathway is operative in a subgroup of tumours; this is characterized by gain of chromosome 14 and is strongly associated with poor prognosis. Predictive fluorescence in situ hybridization analysis of chromosome 14 status in patients with ileal carcinoids is suggested.
Related Articles
Vascular Endothelial Growth Factors, Angiogenesis, and Survival in Human Ileal Enterochromaffin Cell Carcinoids
Neuroendocrinology, 10/15/09
Relevance Score: 66%
Adenocarcinoma in Ileal Pouch after Proctocolectomy for Familial Adenomatous Polyposis: Report of A Case
Journal of Korean Medical Science, 10/14/09
Relevance Score: 45%
Development of Carcinoid Tumour in Hormonally Treated Adenocarcinoma of the Prostate
European Urology, 10/16/09
Relevance Score: 44%
Outcome of Sigmoid Compared to Ileal Orthotopic Bladder Substitution in Terms of Micturition and Defecation Parameters in an 8-Year Long-Term Follow-Up
Urologia Internationalis, 10/21/09
Relevance Score: 43%
A Comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in Pulmonary Neuroendocrine Tumors
The Journal of Nuclear Medicine, 11/16/09
Relevance Score: 42%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Growth Hormone (GH) Deficiency Type II: A Novel GH-1 Gene Mutation (GH-R178H) Affecting Secretion and Action
Journal of Clinical Endocrinology and Metabolism, 12/11/09
Anti Insulin-Like Growth Factor I Receptor Immunoliposomes: A Single Formulation Combining Two Anticancer Treatments with Enhanced Therapeutic Efficiency
Journal of Clinical Endocrinology and Metabolism, 12/11/09
Ghrelin and polypeptide YY in postpartum lactating and nonlactating women
American Journal of Clinical Nutrition, 12/11/09
Today in Endocrine Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Poorly Differentiated Thyroid Carcinoma: 5 Years after the 2004 WHO Classification of Endocrine Tumours
Endocrine Pathology, 12/11/09
Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon alpha for advanced carcinoid tumors: FNCLCC–FFCD 9710
Endocrine-Related Cancer, 12/10/09
Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer
Endocrine-Related Cancer, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


